Applications of (S)-Amino-(4-Chloro-Phenyl)-Acetic Acid in Industrial Manufacturing

(S)-Amino-(4-Chloro-Phenyl)-Acetic Acid is an essential chiral intermediate across specialized pharmaceutical and chemical manufacturing. Its unique stereochemistry and reactivity support high-value synthetic transformations in target applications demanding stringent process control and traceability. We support direct integration of this raw material into multiple regulated downstream processes.

1. Production of Chiral Active Pharmaceutical Ingredients (APIs)

This intermediate is incorporated into API synthesis protocols, specifically for enantiopure drug substances in antihypertensive and CNS-active agent categories. Manufacturers engage our proprietary grade to achieve high-fidelity chiral purity, as required by current Good Manufacturing Practice. The compound is introduced during advanced stepwise coupling reactions, where access to high-purity S-enantiomers determines final API performance and regulatory acceptance.

Industry compliance standards

• ICH Q7: Good Manufacturing Practice for Active Pharmaceutical Ingredients
• 21 CFR Part 211: US FDA Current Good Manufacturing Practice (cGMP)
• EU GMP Directive 2003/94/EC
• USP/NF, Ph. Eur. individual monographs for APIs

Typical usage ratio

• Typically 0.3–1.2 molar equivalents, based on the core backbone structure; exact ratio depends on downstream coupling and chiral resolution requirements

Downstream process integration

• Introduced post initial scaffold assembly, predominantly in asymmetric amination or peptide coupling stages
• Employed under controlled temperature, with inert atmosphere and constant in-process chiral purity monitoring

Final product types

• Sartan antihypertensive drug substances
• CNS modulators requiring single-enantiomer precursors
• Chiral building blocks for further API diversification

2. Synthesis of Agrochemical Intermediates

Our raw material acts as an enantiopure amine precursor in crop protection agent manufacture, including select herbicides and fungicides. The compound supports regioselective synthesis for molecules requiring specific aryl-amino linkages. Agrochemical plants integrate it after halogenation and amidation steps, ensuring precise product identity and compliance with market-specific residue controls.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems for chemical manufacturing
• REACH (EC 1907/2006) registration for downstream environmental releases
• FAO/WHO specifications for pesticide technical materials
• OECD Guidelines for the Testing of Chemicals

Typical usage ratio

• Ranges from 0.8–1.4 molar equivalents, based on the intended arylamine functionalization; excess may be used to drive specific coupling reactions

Downstream process integration

• Fed into condensation reactors after primary alkylation steps
• Used during differential halogen protection/removal for targeted downstream substitutions

Final product types

• Arylamine herbicide technical concentrates
• Fungicide active materials for seed and foliar application
• Precursor molecules for proprietary agrochemical formulations

3. Preparation of Advanced Liquid Chromatography Derivatization Agents

Specialty reagent manufacturers adopt this compound as a core structure for producing chiral derivatization agents. These agents enable high-sensitivity LC and LC-MS analysis of enantiomeric excess and purity for complex pharmaceutical samples. Formulators benefit from the consistent high chiral purity of our material when synthesizing reagents that must not contribute background interference during critical analyses.

Industry compliance standards

• ISO/IEC 17025:2017 Laboratory Accreditation for chemical quality
• Manufacturing according to Analytical Reagent (AR) guidelines
• In-house QA protocols based on Ph. Eur. and USP standards for reference reagents
• GLP (Good Laboratory Practice) for analytical reference material production

Typical usage ratio

• 0.1–1.0 parts by mass within multistep synthesis; precise loading varies with target molecule design and application requirements

Downstream process integration

• Condenses with acyl halides to construct detection-enhancing moieties
• Enters synthesis sequence at initial amination or final esterification step, dependent on the analytical agent structure

Final product types

• Chiral derivatization agents for HPLC and LC-MS analysis
• Analytical grade reference materials
• Specialty diagnostic reagent kits

4. Fine Chemical Synthesis for Custom Peptide and Peptidomimetic Manufacture

Custom synthesis laboratories use the compound as a protected amino acid analog within peptide development programs. Its halogenated aromatic motif supports stable peptide bond formation and fine-tuned electronic properties in peptidomimetic drug candidates. Full compliance with traceability and impurity profiling requirements ensures safe use in preclinical candidate synthesis under regulated environments.

Industry compliance standards

• ICH Q11: Development and Manufacture of Drug Substances
• USP General Chapters <1047> for peptide synthesis materials
• FDA DMF Type II (where applicable for clinical phase support)
• ISO 13485 for medical device-related peptide precursors

Typical usage ratio

• Incorporated at 1.0–1.1 equivalents per coupling step; minor excess deployed to ensure quantitative incorporation with high-purity peptides

Downstream process integration

• Integrated during solid-phase peptide synthesis via Fmoc- or Boc-protected protocols
• Activated before final resin cleavage or amidation steps for introduction of custom sidechains

Final product types

• Chiral peptidomimetic research compounds
• Bioactive peptides with arylated sidechains
• Peptide analogs for diagnostic or therapeutic screening